AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 160 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $124,000 | +103.3% | 8,192 | 0.0% | 0.00% | – |
Q2 2022 | $61,000 | -18.7% | 8,192 | 0.0% | 0.00% | – |
Q1 2022 | $75,000 | +29.3% | 8,192 | 0.0% | 0.00% | – |
Q4 2021 | $58,000 | -37.6% | 8,192 | 0.0% | 0.00% | – |
Q3 2021 | $93,000 | -29.0% | 8,192 | 0.0% | 0.00% | -100.0% |
Q2 2021 | $131,000 | -10.3% | 8,192 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $146,000 | +31.5% | 8,192 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $111,000 | +15.6% | 8,192 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $96,000 | -20.7% | 8,192 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $121,000 | +9.0% | 8,192 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $111,000 | +4.7% | 8,192 | +87.5% | 0.00% | 0.0% |
Q4 2019 | $106,000 | +26.2% | 4,370 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $84,000 | -34.9% | 4,370 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $129,000 | -38.0% | 4,370 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $208,000 | +31.6% | 4,370 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $158,000 | -41.3% | 4,370 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $269,000 | +35.2% | 4,370 | +48.6% | 0.00% | +100.0% |
Q2 2018 | $199,000 | +25.2% | 2,940 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $159,000 | -9.7% | 2,940 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $176,000 | – | 2,940 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |